Barclays PLC Bio N Tech Se Call Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$80.36 - $102.87 $3.62 Million - $4.63 Million
45,000 New
45,000 $3.62 Million
Q4 2023

Feb 15, 2024
BUY
$90.91 - $112.75 $1.36 Million - $1.69 Million
15,000 New
15,000 $1.58 Million
Q1 2023

May 04, 2023
SELL
$122.57 - $153.67 $4.71 Million - $5.9 Million
-38,400 Reduced 71.91%
15,000 $1.87 Million
Q4 2022

Feb 13, 2023
BUY
$118.43 - $186.05 $6.32 Million - $9.94 Million
53,400 New
53,400 $8.02 Million

Others Institutions Holding BNTX

# of Institutions
356
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $26.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email